Aeterna Wealth

Mutual funds holding Biocon shares

101 mutual fund schemes held Biocon shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹9,386 cr in all. The largest holders by value are SBI Contra Fund (3.2% of the fund), SBI Large & Midcap Fund (2.1% of the fund), Kotak Mid Cap Fund (1.0% of the fund).

Against the month before, 0 schemes added Biocon as a new holding and 0 sold out of it completely.

By category: Index Fund (37), Sectoral/Thematic (22), Arbitrage (8), Mid Cap (7), Large & Mid Cap (6), Flexi Cap (6).

9 actively managed schemes holding it are rated A+ or A on their track record, among them SBI Balanced Advantage Fund, SBI MultiCap Fund, SBI Healthcare Opportunities Fund, Mirae Asset Healthcare Fund, Invesco India Flexi Cap Fund.

Every scheme holding Biocon, by value

SchemeRating% of fundValueChange
SBI Contra FundValue / ContraB3.17%₹1,409 cr-0.12
SBI Large & Midcap FundLarge & Mid CapC2.13%₹849 cr-0.07
Kotak Mid Cap FundMid CapC1.03%₹666 cr–
SBI Midcap FundMid CapC2.46%₹548 cr-0.02
Kotak Large & Mid Cap FundLarge & Mid CapB1.57%₹474 cr–
ICICI Prudential Focused FundFocusedC2.69%₹464 cr–
SBI Balanced Advantage FundBalanced AdvantageA+1.15%₹459 cr–
SBI MultiCap FundMulti CapA1.70%₹388 cr-0.04
ICICI Prudential Value Fund (erstwhile Value Discovery Fund)Value / ContraC0.55%₹318 cr–
ICICI Prudential Large Cap Fund (erstwhile Bluechip Fund)Large CapC0.38%₹292 cr–
Franklin India Mid Cap FundMid CapC2.47%₹287 cr–
HDFC Flexi Cap FundFlexi CapB0.25%₹276 cr–
SBI Flexicap FundFlexi CapC1.14%₹247 cr-0.03
Nippon India Focused FundFocusedC3.05%₹243 cr+1.48
Aditya Birla Sun Life Focused FundFocusedB3.03%₹232 cr–
SBI MNC FundSectoral/ThematicB2.58%₹158 cr-0.03
SBI Arbitrage FundArbitrageA+0.34%₹157 cr–
SBI ELSS Tax Saver FundELSSC0.48%₹143 cr-0.02
SBI Dividend Yield FundDividend YieldB1.83%₹143 cr-0.03
SBI Healthcare Opportunities FundSectoral/ThematicA2.17%₹132 cr-0.20
HDFC Large & Mid Cap FundLarge & Mid CapB0.39%₹110 cr–
Canara Robeco Flexi Cap FundFlexi CapB0.76%₹97 cr+0.04
Nippon India Pharma FundSectoral/ThematicC0.97%₹88 cr-0.04
Nippon India Vision Large & Mid Cap FundLarge & Mid CapC1.14%₹84 cr-0.05
ICICI Prudential Innovation FundSectoral/ThematicC1.09%₹81 cr–
Canara Robeco Mid Cap FundMid CapB1.66%₹80 cr+0.18
Mirae Asset Healthcare FundSectoral/ThematicA1.97%₹70 cr-0.03
Invesco India Flexi Cap FundFlexi CapA+1.11%₹61 cr+0.04
HDFC Pharma and Healthcare FundSectoral/ThematicA+1.47%₹54 cr–
Aditya Birla Sun Life Midcap FundMid CapC0.83%₹52 cr–
Nippon India Arbitrage FundArbitrageB0.28%₹50 cr–
SBI ESG Exclusionary Strategy FundSectoral/ThematicB0.91%₹46 cr-0.06
Canara Robeco Multi Cap FundMulti CapB0.80%₹45 cr-0.04
UTI Large & Mid Cap FundLarge & Mid CapB0.71%₹44 cr–
HDFC Manufacturing FundSectoral/Thematic–0.39%₹38 cr–
ICICI Prudential ELSS - Tax Saver FundELSSB0.28%₹37 cr–
Kotak Manufacture in India FundSectoral/ThematicB1.18%₹35 cr–
HDFC Innovation FundSectoral/Thematic–1.02%₹32 cr–
DSP Arbitrage fundArbitrageB0.38%₹26 cr–
Motilal Oswal Nifty Midcap 150 Index FundIndex FundB0.63%₹25 cr-0.01

And 61 more schemes with smaller holdings.

Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.

Common questions

How many mutual funds hold Biocon shares?

101 schemes held Biocon in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹9,386 cr in all.

Which mutual fund holds the most Biocon shares?

By value, SBI Contra Fund: about ₹1,409 cr, 3.17% of the fund.

Where does this data come from?

From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.

This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.

Free portfolio review

Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.

Chat with us